Similarly, high ATP13A3 expression was correlated with poorer outcome in two neuroblastoma cohorts (Fig. 2D,E, Fig. S1), while for ATP13A2 the opposite was observed (Fig. 2F,G, Fig. S2). This evidence concerns the gene ATP13A2 and neuroblastoma.